You are here

patents

Judge sanctions Boston Scientific lawyers in Nevro patent row

Mass Device

Wed, 05/9/18 - 08:28 pm

Boston Scientific

neurostimulation

Lilly, Pfizer, Sanofi lead in patent litigation, report says

Biopharma Dive

Thu, 05/3/18 - 12:11 pm

patent lawsuits

Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia

CP Wire

Wed, 05/2/18 - 07:21 pm

New Patent Related Suit Against Shire Could Have Value Into the Billions

CP Wire

Mon, 04/30/18 - 09:39 am

U.S. court upholds dismissal of $200 million Merck verdict against Gilead

Reuters

Thu, 04/26/18 - 07:31 pm

Gilead Sciences

Interview With Hatch-Waxman Expert Kurt Karst

CP Wire

Tue, 04/24/18 - 07:59 pm

Hatch Waxman Act

Should Sarepta’s patents be seized by the government? Patient advocates pitch controversial drug pricing proposal

Endpoints

Fri, 04/6/18 - 07:39 pm

Sarepta Therapeutics

Duchenne Muscular Dystrophy

Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers

CP Wire

Thu, 04/5/18 - 11:23 am

Par Pharmaceutical

Teva Pharmaceutical

Drug Wars: Companies Fight Patents In Court With A Fortune At Stake

American Council on Science and Health

Fri, 03/30/18 - 05:59 pm

Allergan's much-maligned tribal licensing deal wins reprieve at appeals court

Fierce Pharma

Thu, 03/29/18 - 10:36 pm

Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict

Reuters

Thu, 03/29/18 - 10:01 am

Teva Pharmaceutical

In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen

Endpoints

Fri, 03/23/18 - 09:52 am

Tribe looks to stop patent board’s review of Restasis IP

Drug Delivery Business News

Tue, 03/20/18 - 11:13 am

intellectual property

Appeals court upholds patent ruling for Smith & Nephew

Mass Device

Fri, 03/16/18 - 11:06 am

Alphabet Has Filed 186 Health Care Patents. Watch Out, World

Forbes

Tue, 03/13/18 - 11:58 am

Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’

Endpoints

Fri, 03/9/18 - 11:05 am

inter partes review

Sovereign nonsense: Patent board joins the lineup of critics dissing Allergan’s ‘illusory’ IP deal with the Mohawks

Endpoints

Mon, 02/26/18 - 11:04 pm

Allergan is dealt another setback as patent board shoots down Mohawk patent deal

Stat

Sat, 02/24/18 - 10:33 pm

Gilead wins reprieve in Merck's $2.5B patent lawsuit

Biopharma Dive

Thu, 02/22/18 - 09:52 am

Gilead Sciences

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Reuters

Sun, 02/18/18 - 10:10 am

Gilead Sciences

Pages